EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology

Liang Lou, Shizhe Zhou, Sijia Tan, Menghua Xiang, Wei Wang, Chuang Yuan, Liqian Gao, Qicai Xiao

Frontiers in Pharmacology · 27.02.2023 · 14

DOI: 10.3389/fphar.2023.1137707 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 27.02.2023. Verfasst von Liang Lou und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

5-aminolevulinic acid (ALA) is a clinically approved prodrug involved in intracellular Heme biosynthesis to produce the natural photosensitizer (PS) Protoporphyrin IX (PpIX). ALA based photodynamic therapy (PDT) has been used to treat various malignant and non-malignant diseases. However, natural ALA has disadvantages such as weak lipophilicity, low stability and poor bioavailability, greatly reducing its clinical performance. The emerging nanotechnology is expected to address these limitations and thus improve the therapeutic outcomes. Herein, we summarized important recent advances in the design of ALA-based prodrugs using nanotechnology to improve the efficacy of PDT. The potential limitations and future perspectives of ALA-based nanomedicines are also briefly presented and discussed.

Schlagwörter

Stichwörter der Autor:innen

5-aminolevulinic acidbiotransformationnanotechnologyphotodynamic therapyprodrug

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Lou, L., Zhou, S., Tan, S., Xiang, M., Wang, W., Yuan, C., Gao, L., & Xiao, Q. (2023). Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1137707

Vancouver

Lou L, Zhou S, Tan S, Xiang M, Wang W, Yuan C, et al. Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1137707

BibTeX
@article{Lou2023,
  author = {Lou, Liang and Zhou, Shizhe and Tan, Sijia and Xiang, Menghua and Wang, Wei and Yuan, Chuang and Gao, Liqian and Xiao, Qicai},
  title = {Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1137707}
}
Kostenlos starten →